The aspiration and biopsy needles market is projected to reach USD 1,272 million by 2024 from USD 894 million in 2019, at a CAGR of 7.3%.

Rising prevalence of cancer, increasing preference for minimally invasive procedures, and cancer awareness initiatives by governments and global health organizations are the major factors driving the growth of the aspiration and biopsy needles market.

In this report, the Aspiration and Biopsy Needles market has been segmented based on product type, by site, procedure, end user, and region.
Download a FREE Pdf Brochuer@:- https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=71036825

What the Market Looks Like?
The Report “Aspiration & Biopsy Needles Market by Product (Fine-needle Aspiration, Biopsy (Core & Vacuum Assisted)), Site, Procedure (Image-guided (Ultrasound, MRI, Stereotactic), Nonimage-guided), Enduser (Hospital, Academia) - Global Forecast to 2024”

Biopsy needles accounted for the largest share of the aspiration and biopsy needles market, by product, in 2018.
On the basis of product, the aspiration and biopsy needles market is segmented into aspiration and biopsy needles. The biopsy needles segment accounted for the largest share of the aspiration and biopsy needles market in 2018 due to its widespread adoption in healthcare facilities. This segment is also expected to grow at the highest rate during the forecast period.

The lung segment is expected to register the highest growth rate in the aspiration and biopsy needles market during the forecast period by site, in 2019
On the basis of site, the aspiration and biopsy needles market is segmented into breast, lung, colorectal, prostate, kidney, and bone & bone marrow. The lung segment is expected to register the highest growth rate due to the increasing prevalence of lung cancer.

The Major Players Opearting in the Aspiration and Biopsy Needles Market:
Key players in the Aspiration and Biopsy Needles Market include CONMED Corporation (US), Medtronic Plc (Ireland), Olympus (Japan), Becton, Dickinson and Company (US), Boston Scientific Corporation (US), Cook Group Incorporated (US), Argon Medical Devices, Inc (US), INRAD Inc. (US), Somatex Medical Technologies (Germany), Stryker Corporation (US), Cardinal Health (US), Remington Medical (US), HAKKO CO.,LTD (Japan), and Merit Medical Systems (US)

Get a FREE Request Sample Report@:- https://www.marketsandmarkets.com/requestsampleNew.asp?id=71036825

Geographical Detailed Analysis for Aspiration and Biopsy Needles Market:
North America held the largest share of the aspiration and biopsy needles market in 2019
The large share of the North American market can mainly be attributed to the increasing number of surgical procedures, technological advancements, rising demand for minimally invasive procedures, favorable reimbursement scenario, and rising government concerns regarding the health hazards of surgical plumes.

Recent Developments Product

Launches and Approvals
• In September 2018, Olympus (Japan) received FDA approval for its EZ Shot Plus 25 G needle
• In April 2016, Olympus (Japan) launched aspiration biopsy needles with Side Port - Reusable (NA-2C-1)
• In November 2015, Cook Group (US) Incorporated launched EchoTip ProCore 20 Gage Needle for ultrasound-guided fine needle biopsy (FNB)

Acquisitions
• In January 2019, IZI Medical Products acquired Cook Medical’s soft tissue biopsy and breast localization needle product line.
• In February 2018, Merit Medical Systems, Inc. announced the closure of its purchase of divestment assets from BD (Becton, Dickinson and Company)